Skip to main content

Table 3 The mRNA expression of β2M, HER2, HIF-1α, VEGF and Bcl-2 in two types of breast cancer tissues

From: β2-microglobulin has a different regulatory molecular mechanism between ER+ and ER breast cancer with HER2

  Luminal A (n = 29) Basal-like (n = 9)
Fold-change median (range) Z p Fold-change median (range) Z p
β2M 0.9202 (0.18–7.29) − 0.622 0.534 0.6395 (0.25–2.32) − 0.652 0.515
HER2 1.0755 (0.20–5.00) −1.314 0.189 0.7955 (0.01–8.31) − 0.889 0.374
HIF-1α 1.0281 (0.05–6.43) −0.400 0.689 0.7346 (0.21–2.34) −0.652 0.515
VEGF 0.9526 (0.19–7.86) −0.119 0.905 1.0070 (0.02–3.59) −0.296 0.767
Bcl-2 1.1154 (0.11–9.61) −1.571 0.116 0.3015 (0.04–3.10) −0.652 0.515
  1. n The number of patients with breast cancer